A study out of Brazil suggests that a simple, low-cost supplement could meaningfully improve how well chemotherapy works against breast cancer. Researchers at the Botucatu School of Medicine at São Paulo State University (FMB-UNESP) found that women who took daily vitamin D alongside chemotherapy were 79% more likely to achieve complete tumor disappearance than women who took a placebo.
At a glance
- Vitamin D supplementation: Women took 2,000 IU of vitamin D daily during chemotherapy — a modest, cost-effective dose rather than a high corrective one.
- Complete response rate: 43% of women in the vitamin D group saw their cancer fully disappear, compared to 24% in the placebo group.
- Study population: 80 women aged 45 and older, all receiving chemotherapy before surgery to shrink their tumors, most of whom were vitamin D-deficient at the start.
Why this finding matters
Breast cancer is the most commonly diagnosed cancer in women worldwide. Chemotherapy before surgery — called neoadjuvant chemotherapy — is a standard approach for many patients, and how completely the tumor responds to that treatment is a strong predictor of long-term outcomes.
A therapy that costs a few dollars a month and could raise the complete response rate by that margin is worth taking seriously. The researchers note that vitamin D is widely available, easy to take, and carries a well-established safety profile at this dose.
Most women in the study were deficient in vitamin D before treatment began — a common finding in cancer patients and in the general population. Correcting that deficiency during chemotherapy may have given the immune system more to work with.
How vitamin D may support cancer treatment
Vitamin D is best known for its role in bone health, but its influence on the immune system runs deeper. It helps regulate immune cell activity and has been shown in lab studies to affect how cancer cells grow and die. The UNESP researchers believe restoring adequate vitamin D levels may help the body respond more aggressively to the cancer during treatment.
What makes the UNESP approach notable is the dose. Rather than using the high supplementation levels sometimes used to rapidly correct deficiency, the team used 2,000 IU daily — a level considered safe for long-term use and practical for integration into a standard treatment plan.
Limitations and next steps
The researchers are careful not to overstate the results. The trial included only 80 participants, and the findings have not yet been replicated at scale. Larger, randomized clinical trials are needed before vitamin D can be formally recommended as a routine add-on for breast cancer chemotherapy.
Still, the direction of the finding is clear and the cost of further investigation is low. The research was published in a peer-reviewed oncology context and adds to a growing body of evidence linking nutritional status and cancer treatment outcomes.
Vitamin D deficiency is also not evenly distributed. Populations with darker skin tones, limited sun exposure, and lower incomes face higher deficiency rates — meaning an affordable supplement-based intervention could matter most for communities that already face worse cancer outcomes. That equity angle is one more reason researchers say follow-up work is urgent.
For now, the UNESP team recommends that oncologists consider testing patients’ vitamin D levels at the start of treatment. Supplementation at a modest dose carries little risk and, if this study holds up, may meaningfully shift the odds in a patient’s favor.
Read more
For more on this story, see: OnlyMyHealth
For more from Good News for Humankind, see:
- U.K. cancer death rates fall to their lowest level on record
- Alzheimer’s risk cut in half by drug in landmark prevention trial
- The Good News for Humankind archive on global health
About this article
- 🤖 This article is AI-generated, based on a framework created by Peter Schulte.
- 🌍 It aims to be inspirational but clear-eyed, accurate, and evidence-based, and grounded in care for the Earth, peace and belonging for all, and human evolution.
- 💬 Leave your notes and suggestions in the comments below — I will do my best to review and implement where appropriate.
- ✉️ One verified piece of good news, one insight from Antihero Project, every weekday morning. Subscribe free.
More Good News
-
More than 10% of the world’s oceans now officially protected
Ocean protection just crossed a historic line: as of April 2026, 10.01% of the world’s seas are officially designated as protected, up from 8.6% just two years ago. That leap represents roughly 5 million square kilometers of newly safeguarded waters — an expanse larger than the entire European Union. The milestone fulfills a promise the world first made back in 2010, and it arrived thanks to thousands of small wins: national designations, community-led projects, and Indigenous stewardship of some of the most intact marine ecosystems on Earth. With the UN High Seas Treaty now in force, nations finally have a…
-
Nearly 20 million measles deaths averted in Africa since 2000
Measles vaccines in Africa have prevented an estimated 19.5 million deaths since 2000 — roughly 800,000 lives saved every year for nearly a quarter century. A new WHO and Gavi analysis credits steady investment in cold-chain systems, community health workers, and political will, with coverage for the critical second measles dose climbing more than tenfold over that stretch. This year, Cabo Verde, Mauritius, and Seychelles became the first sub-Saharan nations to officially eliminate measles and rubella, a milestone once considered out of reach. The story is a powerful reminder that global health progress, though uneven, compounds quietly over decades —…
-
Romania finally recognizes trans man’s identity in landmark E.U. victory
Romanian trans rights took a real leap forward this week, as courts finally ordered the government to legally recognize Arian Mirzarafie-Ahi as male — a recognition the U.K. granted him back in 2020. For years, he lived with two identities depending on which border he crossed, until his case climbed all the way to the E.U.’s top court and came home with a binding answer. That ruling now obligates every E.U. member state to honor gender recognition documents issued by another. It’s a quiet but powerful shift: transgender people across Europe gain stronger footing not through new laws, but through…
